{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:30:44Z","timestamp":1787671844660,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Prevention and Control of Emerging and Major Infectious Disease-National Science and Technology Major Projec","award":["2025ZD01903600"],"award-info":[{"award-number":["2025ZD01903600"]}]},{"name":"Beijing High-level Public Health Project","award":["G2024-2-007"],"award-info":[{"award-number":["G2024-2-007"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["32394013"],"award-info":[{"award-number":["32394013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Prevention and Control of Emerging and Major Infectious Disease-National Science and Technology Major Project","award":["2025ZD01903603"],"award-info":[{"award-number":["2025ZD01903603"]}]},{"name":"Beijing Natural Science Foundation","award":["7242025"],"award-info":[{"award-number":["7242025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00210-026-05423-5","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:21:04Z","timestamp":1779348064000},"page":"17277-17289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative extracellular and intracellular anti-Mycobacterium tuberculosis activity of three tanshinones from Salvia miltiorrhiza and oral cryptotanshinone efficacy in mice"],"prefix":"10.1007","volume":"399","author":[{"given":"Xinyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanzhi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongde","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"5423_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2024.107074","volume":"198","author":"PK Agnivesh","year":"2025","unstructured":"Agnivesh PK, Roy A, Sau S, Kumar S, Kalia NP (2025) Advancements and challenges in tuberculosis drug discovery: a comprehensive overview. Microb Pathog 198:107074","journal-title":"Microb Pathog"},{"key":"5423_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1063453","volume":"13","author":"JC Alffenaar","year":"2022","unstructured":"Alffenaar JC, de Steenwinkel JEM, Diacon AH, Simonsson USH, Srivastava S, Wicha SG (2022) Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: an evaluation of in vitro, in vivo methodologies and human studies. Front Pharmacol 13:1063453","journal-title":"Front Pharmacol"},{"key":"5423_CR3","unstructured":"Anonymous. Global tuberculosis report 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"5423_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.bi.64.070195.000333","volume":"64","author":"PJ Brennan","year":"1995","unstructured":"Brennan PJ, Nikaido H (1995) The envelope of mycobacteria. Annu Rev Biochem 64:29\u201363","journal-title":"Annu Rev Biochem"},{"key":"5423_CR5","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/med.21304","volume":"34","author":"X Chen","year":"2014","unstructured":"Chen X, Guo J, Bao J, Lu J, Wang Y (2014) The anticancer properties of Salvia miltiorrhiza Bunge (Danshen): a systematic review. Med Res Rev 34:768\u2013794","journal-title":"Med Res Rev"},{"key":"5423_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104254","volume":"145","author":"X Chen","year":"2019","unstructured":"Chen X, Yu J, Zhong B, Lu J, Lu JJ, Li S, Lu Y (2019) Pharmacological activities of dihydrotanshinone I, a natural product from Salvia miltiorrhiza Bunge. Pharmacol Res 145:104254","journal-title":"Pharmacol Res"},{"key":"5423_CR7","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1023\/A:1016091631721","volume":"13","author":"AM Clark","year":"1996","unstructured":"Clark AM (1996) Natural products as a resource for new drugs. Pharm Res 13:1133\u20131144","journal-title":"Pharm Res"},{"key":"5423_CR8","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1901814","volume":"382","author":"F Conradie","year":"2020","unstructured":"Conradie F, Diacon AH, Ngubane N, Howell P, Everitt D, Crook AM, Mendel CM, Egizi E, Moreira J, Timm J, McHugh TD, Wills GH, Bateson A, Hunt R, Van Niekerk C, Li M, Olugbosi M, Spigelman M, Nix TBTT (2020) Treatment of highly drug-resistant pulmonary tuberculosis. N Engl J Med 382:893\u2013902","journal-title":"N Engl J Med"},{"key":"5423_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.106040","volume":"81","author":"S Cui","year":"2020","unstructured":"Cui S, Chen S, Wu Q, Chen T, Li S (2020) A network pharmacology approach to investigate the anti-inflammatory mechanism of effective ingredients from Salvia miltiorrhiza. Int Immunopharmacol 81:106040","journal-title":"Int Immunopharmacol"},{"key":"5423_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrmicro3200","volume":"12","author":"V Dartois","year":"2014","unstructured":"Dartois V (2014) The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells. Nat Rev Microbiol 12:159\u2013167","journal-title":"Nat Rev Microbiol"},{"key":"5423_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1039\/c0np00035c","volume":"28","author":"Y Dong","year":"2011","unstructured":"Dong Y, Morris-Natschke SL, Lee KH (2011) Biosynthesis, total syntheses, and antitumor activity of tanshinones and their analogs as potential therapeutic agents. Nat Prod Rep 28:529\u2013542","journal-title":"Nat Prod Rep"},{"key":"5423_CR12","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1093\/jac\/dkw014","volume":"71","author":"NK Dutta","year":"2016","unstructured":"Dutta NK, Bruiners N, Pinn ML, Zimmerman MD, Prideaux B, Dartois V, Gennaro ML, Karakousis PC (2016) Statin adjunctive therapy shortens the duration of TB treatment in mice. J Antimicrob Chemother 71:1570\u20131577","journal-title":"J Antimicrob Chemother"},{"key":"5423_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108894","volume":"108","author":"LM Fan","year":"2022","unstructured":"Fan LM, Zhang YQ, Chen YP, Chen LL, Xu WH, Nan LH, Xu W, Lu B, Wang Y, Chu KD, Zhang JP (2022) Cryptotanshinone ameliorates dextran sulfate sodium-induced murine acute and chronic ulcerative colitis via suppressing STAT3 activation and Th17 cell differentiation. Int Immunopharmacol 108:108894","journal-title":"Int Immunopharmacol"},{"key":"5423_CR14","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/S0140-6736(19)30308-3","volume":"393","author":"J Furin","year":"2019","unstructured":"Furin J, Cox H, Pai M (2019) Tuberculosis. Lancet 393:1642\u20131656","journal-title":"Lancet"},{"key":"5423_CR15","doi-asserted-by":"publisher","first-page":"33720","DOI":"10.1038\/srep33720","volume":"6","author":"H Gao","year":"2016","unstructured":"Gao H, Sun W, Zhao J, Wu X, Lu JJ, Chen X, Xu QM, Khan IA, Yang S (2016) Tanshinones and diethyl blechnics with anti-inflammatory and anti-cancer activities from Salvia miltiorrhiza Bunge (Danshen). Sci Rep 6:33720","journal-title":"Sci Rep"},{"key":"5423_CR16","doi-asserted-by":"publisher","first-page":"e3004","DOI":"10.1038\/cddis.2017.389","volume":"8","author":"H Gao","year":"2017","unstructured":"Gao H, Liu X, Sun W, Kang N, Liu Y, Yang S, Xu QM, Wang C, Chen X (2017) Total tanshinones exhibits anti-inflammatory effects through blocking TLR4 dimerization via the MyD88 pathway. Cell Death Dis 8:e3004","journal-title":"Cell Death Dis"},{"key":"5423_CR17","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1128\/AAC.00464-12","volume":"56","author":"M Gonzalez-Juarrero","year":"2012","unstructured":"Gonzalez-Juarrero M, Woolhiser LK, Brooks E, DeGroote MA, Lenaerts AJ (2012) Mouse model for efficacy testing of antituberculosis agents via intrapulmonary delivery. Antimicrob Agents Chemother 56:3957\u20133959","journal-title":"Antimicrob Agents Chemother"},{"key":"5423_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/916521","volume":"2014","author":"AC Helguera-Repetto","year":"2014","unstructured":"Helguera-Repetto AC, Chacon-Salinas R, Cerna-Cortes JF, Rivera-Gutierrez S, Ortiz-Navarrete V, Estrada-Garcia I, Gonzalez-y-Merchand JA (2014) Differential macrophage response to slow- and fast-growing pathogenic mycobacteria. BioMed Res Int 2014:916521","journal-title":"BioMed Res Int"},{"key":"5423_CR19","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1016\/j.bmcl.2008.07.071","volume":"18","author":"JD Hughes","year":"2008","unstructured":"Hughes JD, Blagg J, Price DA, Bailey S, Decrescenzo GA, Devraj RV, Ellsworth E, Fobian YM, Gibbs ME, Gilles RW, Greene N, Huang E, Krieger-Burke T, Loesel J, Wager T, Whiteley L, Zhang Y (2008) Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorg Med Chem Lett 18:4872\u20134875","journal-title":"Bioorg Med Chem Lett"},{"key":"5423_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116289","volume":"173","author":"M Imran","year":"2024","unstructured":"Imran M, Singh S, Ahmad MN, Malik P, Mukhopadhyay A, Yadav KS, Gupta UD, Mugale MN, Mitra K, Srivastava KK, Chopra S, Mignani S, Apartsin E, Majoral JP, Dasgupta A (2024) Polycationic phosphorous dendrimer potentiates multiple antibiotics against drug-resistant mycobacterial pathogens. Biomed Pharmacother 173:116289","journal-title":"Biomed Pharmacother"},{"key":"5423_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cbi.2017.10.013","volume":"278","author":"DH Kim","year":"2017","unstructured":"Kim DH, Paudel P, Yu T, Ngo TM, Kim JA, Jung HA, Yokozawa T, Choi JS (2017) Characterization of the inhibitory activity of natural tanshinones from Salvia miltiorrhiza roots on protein tyrosine phosphatase 1B. Chem Biol Interact 278:65\u201373","journal-title":"Chem Biol Interact"},{"key":"5423_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e21216","volume":"9","author":"Y Kong","year":"2023","unstructured":"Kong Y, Geng Z, Jiang G, Jia J, Wang F, Jiang X, Gu Y, Qi Z, Chu N, Huang H, Yu X (2023) Comparison of the in vitro antibacterial activity of ofloxacin, levofloxacin, moxifloxacin, sitafloxacin, finafloxacin, and delafloxacin against Mycobacterium tuberculosis strains isolated in China. Heliyon 9:e21216","journal-title":"Heliyon"},{"key":"5423_CR23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature09657","volume":"469","author":"A Koul","year":"2011","unstructured":"Koul A, Arnoult E, Lounis N, Guillemont J, Andries K (2011) The challenge of new drug discovery for tuberculosis. Nature 469:483\u2013490","journal-title":"Nature"},{"key":"5423_CR24","doi-asserted-by":"publisher","first-page":"114595","DOI":"10.1016\/j.jep.2021.114595","volume":"282","author":"Y Li","year":"2022","unstructured":"Li Y, Fu Y, Sun J, Shen J, Liu F, Ning B, Lu Z, Wei L, Jiang X (2022) Tanshinone IIA alleviates NLRP3 inflammasome-mediated pyroptosis in Mycobacterium tuberculosis-(H37Ra-) infected macrophages by inhibiting endoplasmic reticulum stress. J Ethnopharmacol 282:114595","journal-title":"J Ethnopharmacol"},{"key":"5423_CR25","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1111\/bph.13068","volume":"172","author":"Z Liu","year":"2015","unstructured":"Liu Z, Xu S, Huang X, Wang J, Gao S, Li H, Zhou C, Ye J, Chen S, Jin ZG, Liu P (2015) Cryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E-deficient mice: role of lectin-like oxidized LDL receptor-1 (LOX-1). Br J Pharmacol 172:5661\u20135675","journal-title":"Br J Pharmacol"},{"key":"5423_CR26","first-page":"145","volume":"6","author":"S Ma","year":"2012","unstructured":"Ma S, Yang D, Wang K, Tang B, Li D, Yang Y (2012) Cryptotanshinone attenuates isoprenaline-induced cardiac fibrosis in mice associated with upregulation and activation of matrix metalloproteinase-2. Mol Med Rep 6:145\u2013150","journal-title":"Mol Med Rep"},{"key":"5423_CR27","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1176\/ajp.146.9.1185","volume":"146","author":"LR Marcos","year":"1989","unstructured":"Marcos LR (1989) Media power and public mental health policy. Am J Psychiatry 146:1185\u20131189","journal-title":"Am J Psychiatry"},{"key":"5423_CR28","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1378\/chest.76.6.771","volume":"76","author":"DA Mitchison","year":"1979","unstructured":"Mitchison DA (1979) Basic mechanisms of chemotherapy. Chest 76:771\u2013781","journal-title":"Chest"},{"key":"5423_CR29","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM (2020) Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod 83:770\u2013803","journal-title":"J Nat Prod"},{"key":"5423_CR30","doi-asserted-by":"publisher","first-page":"e00900-17","DOI":"10.1128\/AAC.00900-17","volume":"61","author":"Y Pang","year":"2017","unstructured":"Pang Y, Zong Z, Huo F, Jing W, Ma Y, Dong L, Li Y, Zhao L, Fu Y, Huang H (2017) In vitro drug susceptibility of bedaquiline, delamanid, linezolid, clofazimine, moxifloxacin, and gatifloxacin against extensively drug-resistant tuberculosis in Beijing, China. Antimicrob Agents Chemother 61:e00900-17","journal-title":"Antimicrob Agents Chemother"},{"key":"5423_CR31","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1128\/CMR.5.4.420","volume":"5","author":"LR Peterson","year":"1992","unstructured":"Peterson LR, Shanholtzer CJ (1992) Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance. Clin Microbiol Rev 5:420\u2013432","journal-title":"Clin Microbiol Rev"},{"key":"5423_CR32","doi-asserted-by":"publisher","DOI":"10.1039\/d5md00637f","author":"G Polinario","year":"2025","unstructured":"Polinario G, Rosa M, Campos DL, Moraes LLS, de Campos MMA, Silva IGM, Barros-Cordeiro KB, Bao SN, Pavan FR (2025) Tanshinones target drug-resistant tuberculosis: efficacy, selectivity, and potential mechanism of action. RSC Med Chem. https:\/\/doi.org\/10.1039\/d5md00637f","journal-title":"RSC Med Chem"},{"key":"5423_CR33","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1055\/s-2006-957696","volume":"63","author":"SY Ryu","year":"1997","unstructured":"Ryu SY, Lee CO, Choi SU (1997) In vitro cytotoxicity of tanshinones from Salvia miltiorrhiza. Planta Med 63:339\u2013342","journal-title":"Planta Med"},{"key":"5423_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01635434","volume":"31","author":"M Seligmann","year":"1975","unstructured":"Seligmann M (1975) Alpha heavy chain disease. Blut 31:1\u20134","journal-title":"Blut"},{"key":"5423_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13046-020-01595-x","volume":"39","author":"X Wang","year":"2020","unstructured":"Wang X, Wang Q, Li W, Zhang Q, Jiang Y, Guo D, Sun X, Lu W, Li C, Wang Y (2020) TFEB-NF-kappaB inflammatory signaling axis: a novel therapeutic pathway of Dihydrotanshinone I in doxorubicin-induced cardiotoxicity. J Exp Clin Cancer Res 39:93","journal-title":"J Exp Clin Cancer Res"},{"key":"5423_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1517\/17460441003605098","volume":"5","author":"MJ Waring","year":"2010","unstructured":"Waring MJ (2010) Lipophilicity in drug discovery. Expert Opin Drug Discov 5:235\u2013248","journal-title":"Expert Opin Drug Discov"},{"key":"5423_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02747-4","volume":"7","author":"L Xing","year":"2017","unstructured":"Xing L, Tan ZR, Cheng JL, Huang WH, Zhang W, Deng W, Yuan CS, Zhou HH (2017) Bioavailability and pharmacokinetic comparison of tanshinones between two formulations of Salvia miltiorrhiza in healthy volunteers. Sci Rep 7:4709","journal-title":"Sci Rep"},{"key":"5423_CR38","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.1128\/AAC.00393-16","volume":"60","author":"X Yu","year":"2016","unstructured":"Yu X, Wang G, Chen S, Wei G, Shang Y, Dong L, Schon T, Moradigaravand D, Parkhill J, Peacock SJ, Koser CU, Huang H (2016) Wild-type and non-wild-type Mycobacterium tuberculosis MIC distributions for the novel fluoroquinolone antofloxacin compared with those for ofloxacin, levofloxacin, and moxifloxacin. Antimicrob Agents Chemother 60:5232\u20135237","journal-title":"Antimicrob Agents Chemother"},{"key":"5423_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.phrs.2019.02.017","volume":"142","author":"R Yuan","year":"2019","unstructured":"Yuan R, Huang L, Du LJ, Feng JF, Li J, Luo YY, Xu QM, Yang SL, Gao H, Feng YL (2019) Dihydrotanshinone exhibits an anti-inflammatory effect in vitro and in vivo through blocking TLR4 dimerization. Pharmacol Res 142:102\u2013114","journal-title":"Pharmacol Res"},{"key":"5423_CR40","doi-asserted-by":"publisher","first-page":"13621","DOI":"10.3390\/ijms131013621","volume":"13","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Jiang P, Ye M, Kim SH, Jiang C, Lu J (2012) Tanshinones: sources, pharmacokinetics and anti-cancer activities. Int J Mol Sci 13:13621\u201313666","journal-title":"Int J Mol Sci"},{"key":"5423_CR41","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1177\/0091270005282630","volume":"45","author":"L Zhou","year":"2005","unstructured":"Zhou L, Zuo Z, Chow MS (2005) Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45:1345\u20131359","journal-title":"J Clin Pharmacol"},{"key":"5423_CR42","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nrd4001","volume":"12","author":"A Zumla","year":"2013","unstructured":"Zumla A, Nahid P, Cole ST (2013) Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Discov 12:388\u2013404","journal-title":"Nat Rev Drug Discov"},{"key":"5423_CR43","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/S1473-3099(16)00078-5","volume":"16","author":"A Zumla","year":"2016","unstructured":"Zumla A, Rao M, Wallis RS, Kaufmann SH, Rustomjee R, Mwaba P, Vilaplana C, Yeboah-Manu D, Chakaya J, Ippolito G, Azhar E, Hoelscher M, Maeurer M, Host-Directed Therapies Network c. (2016) Host-directed therapies for infectious diseases: current status, recent progress, and future prospects. Lancet Infect Dis 16:e47-63","journal-title":"Lancet Infect Dis"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05423-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05423-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05423-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:06:25Z","timestamp":1787670385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05423-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5423"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05423-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of Shenzhen University (IACUC202300031). Animal studies were performed in compliance with the ARRIVE guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}